Publications by authors named "P R Guilbert"

Introduction: Patients with a head and neck (HN) cancer undergoing radiotherapy risk critical weight loss and oral intake reduction leading to enteral nutrition. We developed a predictive model for the need for enteral nutrition during radiotherapy in this setting. Its performances were reported on a real-world multicentric cohort.

View Article and Find Full Text PDF
Article Synopsis
  • Optimizations in immunotherapy for Triple-negative breast cancer (TNBC) show promise, particularly in targeting galectin-9 (Gal-9) after radiotherapy.
  • In TNBC patients receiving neoadjuvant radiotherapy, higher Gal-9 levels were observed in non-responders compared to baseline, indicating a potential link between Gal-9 expression and treatment response.
  • A study in mice showed that targeting Gal-9 with an antibody led to reduced tumor growth only in those injected with irradiated cancer cells, suggesting Gal-9's potential as a biomarker and therapeutic target in TNBC.
View Article and Find Full Text PDF

Intestinal goblet cells are secretory cells specialized in the production of mucins, and as such are challenged by the need for efficient protein folding. Goblet cells express Inositol-Requiring Enzyme-1β (IRE1β), a unique sensor in the unfolded protein response (UPR), which is part of an adaptive mechanism that regulates the demands of mucin production and secretion. However, how IRE1β activity is tuned to mucus folding load remains unknown.

View Article and Find Full Text PDF

Skin reaction is a common toxicity during oncology management, especially followed during the radiotherapy. Its assessment and understanding of the factors influencing its occurrence, is a major issue in the management of patients treated for an early breast cancer (BC). We evaluated 8561 patients during their overall management for a BC.

View Article and Find Full Text PDF

The aim of the data farming project by the Unitrad group is to produce and use large quantities of structured real-life data throughout radiotherapy treatment. Starting in 2016, target real world data were selected at expert consensus conferences and regularly updated, then captured in MOSAIQ© as the patient was treated. For each partner institution, the data was then stored in a relational database, then extracted and used by researchers to create real world knowledge.

View Article and Find Full Text PDF